Prot# 2005NMMF-201-US: A Phase II Pivotal Trial to Evaluate the Safety and Efficacy of Nitrogen Mustard (NM) 0.02% Ointment Formulations in Patients with Stage I or IIA Mycosis Fungoides (MF)

Project: Research project

Project Details

StatusFinished
Effective start/end date6/13/07 → 2/1/12

Funding

  • Ceptaris Therapeutics Inc. (2005NMMF-201-US)